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Background/aim: Acute cerebral infarction (ACI) occurs as a result of instant disruption of vascular flow that causes disbalance
between oxidative/antioxidative activity. We examined the relationship of serum neuro-oxidative stress parameters with stroke severity
and infarct volume in ACI and emphasized the qualitative importance of high-density lipoprotein (HDL) on its relationship with
myeloperoxidase (MPO) and paraoxonase-1 (PON1) in the acute period of stroke.
Materials and methods: One hundred ACI patients applied within the first 24 h and 50 healthy volunteers were included. The patient
group was evaluated with demographic data (including arrival serum biochemical assessment), clinical disability scores, infarct
volume, serum oxidative/antioxidative parameters (lipid hydroperoxide (LOOH), MPO, PON1, MPO/PON ratio). The relevant serum
parameters were compared with the control group. Dysfunctional HDL measurement was based on detecting dysfunctionality as a result
of a high positive correlation between the dysfunctional feature of HDL and the MPO/PON ratio. The correlation of serum parameters,
clinical disability score, and infarct volume were evaluated, and independent analyses of variability with comorbidities were performed.
Results: A negative correlation between PON1 and arrival NIH score/scale (NIHSS), LOOH and discharge modified rankin scale
(mRS), triglyceride level, and infarct volume; a positive correlation between MPO\PON ratio and infarct volume was determined.
Logistic regression analyses showed that hypertension, diabetes, and high HbA1C may be predictors of stroke severity, and diabetes
mellitus, high HbA1C, infarct volume, and high NIHSS score may be predictors of early disability (p < 0.005). The ROC curve
analysis revealed that determining the cut-off value for LOOH is of importance in determining early disability scores (7.2 and 6.2,
respectively).
Conclusion: The balance between oxidative and antioxidative stress parameters and their quantitative/qualitative changes is of
importance, especially in the acute period of ACI. Dysfunctional HDL’s evolution and its relationship with other oxidants are significant
not only in the cardiovascular aspect but also in the clinicoradiological aspect.
Key words: Dysfunctional HDL, infarct volume, lipid hydroperoxide, myeloperoxidase, oxidative stress

1. Introduction
Stroke, according to the definition of the World Health
Organization, is a clinical syndrome characterized by
a rapid settlement of signs and symptoms of focal loss
of cerebral function for no apparent reason other than
vascular causes. Symptoms last longer than 24 h and
may result in death [1]. Stroke can be classified into 2
categories, hemorrhagic and ischemic, the latter being the
most prevalent form accounting for up to 87% of all cases
[2]. A significant proportion of ischemic stroke is caused
by atherothrombosis, defined as atherosclerotic plaque
disruption with superimposed thrombosis [3].

Unlike other organs, the brain is especially vulnerable
to ROS and RNS increases due to low neuron antioxidant
enzyme activity and high concentrations of peroxidizable
lipids, high O2 consumption, and high levels of iron, all
acting as prooxidants under pathological conditions [4].
In agreement with this view, ROS production has been
reported as an important mechanism of brain injury after
exposure to ischemia and reperfusion [5].
High-density lipoproteins (HDLs) are complex
particles containing multiple proteins that have been
reported to be modified under pathological conditions
[6-9]. Although it has been shown in several studies that
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the functionality of HDL rather than HDL level is effective
on cardiovascular disease risk in cardiovascular diseases,
there are not enough studies yet in this area in stroke
patients.
In this study, we aimed to reveal whether the severity
of the stroke, the extent of ischemia, and atherosclerosis
is related to HDL level or its functional capacity, and to
illuminate dysfunctional HDL, LOOH, MPO serum level
changes in patients with acute stroke in the first 24 h in
terms of their prognostic superiority to each other and the
effect of each on infarct volume and clinical disability. Due
to the lack of sufficient studies and projects in this field,
our study will be an eye-opener for many researchers in
this respect.
2. Materials and methods
2.1. Study design and patient cohort
This single-center, prospective study was conducted
with 100 patients aged 18–80 years who applied to the
emergency department with acute ischemic stroke in the
first 24 h and were hospitalized in the neurology clinic,
and 50 control group patients admitted to the neurology
outpatient clinic between April 2020 and September 2020.
The study was carried out after obtaining the written
consent of each participant. Participants in the control
group to be included were selected from individuals
without signs of intracranial disease such as stroke,
intracerebral hemorrhage, tumor, demyelinating disease,
and intracerebral parenchymal or meningeal infection.
Persons to be selected for the patient group with a history
of other intracranial diseases that could be included in the
differential diagnosis of stroke were excluded from the
study. To determine the demographic data (i.e. age, sex,
race, and chronic diseases) were recorded in the data forms.
In the clinical evaluations of the patients, early disability
was determined for each patient using the hospitalization/
discharge NIHSS score and the discharge mRS.
2.2. Imaging analysis
Infarction volume was calculated in the diffusion (DWI)
sequence in cranial magnetic resonance imaging (MRI)
of all patients. The area calculation of the infarct was
made with the Freehand ROI tool in the DWI sections
using the AW Volume Share 7 workstation, this area
information obtained from each section was collected and
then the volume information was created by multiplying
the section thickness by 5 mm and the interslice gap of 1
mm (6 mm). A clinical neurologist (E.D.U.) experienced
in stroke imaging independently performed an image
review. Reviewers were blinded to biological, therapeutic,
and imaging follow-up outcomes but had details about the
demographic data and clinical appearance of the cases.
Neither of the reviewers had taken part in the selection of
the patients.
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2.3. Preparation of blood samples and measurements
Five milliliters of blood samples were taken to the
heparinized vacutainer tube from the stroke patients
(within the first 24 h of stroke) and the control group
patients. The blood samples were immediately centrifuged
for 10 min at a speed of 1300 × g in a Hettich centrifuge
device and the plasmas were separated. Plasma samples
were stored in the freezer at –80 °C until the measurement
time.
2.3.1. Evaluation of plasma dysfunctional HDL level and
PON1 activity
Dysfunctional HDL measurement was based on the
principle of detecting the dysfunction of HDL in the
rate of MPO/PON by the method defined by Haraguchi
et al. [10]. PON1 measurement was carried out based on
spectrophotometric measurement of 4-nitrophenol, which
is formed as a result of enzymatic hydrolysis of paraoxon
used as a substrate, at a wavelength of 412 nm. For basal
PON activity measurement, 50 µL of serum 2 mmol/L
paraoxon (O, O-diethyl-Op-nitrophenyl phosphate.
Sigma chemical, St. lois, Mo., USA), 1-mL Tris-HCL
(Tris(hydroxymethyl) aminomethane) was added to the
buffer (100 mmol/L, Ph:8). PON enzyme activity was used
as a molar extinction coefficient of 17, 1000 M-1 cm. The
amount of 1 nm of 4-nitrophenol PON to be formed per
minute per milliliter of serum was accepted as a unit.
2.3.2. Evaluation of plasma myeloperoxidase level
MPO levels were measured using commercially available
Human MPO ELISA kits (Cayman Chemical, Michigan,
USA). For the human MPO ELISA kit, the detection
interval in the analysis of samples is 0.2–10 ng/mL and
its sensitivity is 0.2 ng/Ml. The within-run and interstudy
CV (coefficient of variation) is 3.83% and 8.13%,
respectively. In the first step, wells covered with MPO were
encompassed with diluted patient samples. In the second
stage, the enzyme affected by antihuman IgG was used
and incubation was performed again. The intensity of this
color, which was formed by providing a color formation
as a result of the enzymatic reaction, was scaled in direct
proportion to the antibody concentration created against
MPO.
2.3.3. Evaluation of plasma lipid hydroperoxides level
LOOH was measured with the xynelol orange method.
The method was applied according to the principle
of oxidation of Fe+2 (Ferrous sulfate) to Fe+3 (ferric
polymaltose) by LOHH in the acidic environment
described by Jiang et al. [11]. The Fe+3 formed was
measured spectrophotometrically with a purple dye
with maximum absorbance at 550–570 nm by forming
a complex of xynelol orange (o-cresosulfonephtaleinxynelol 3,30-bismethylimino-diacetic acid; XOF). Roche
brand Cobas C 501 automatic analyzer was used for
spectrophotometric measurements.
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2.4. Statistical analysis
SPPS 25 (IBM Corp. Released 2017) statistical package
program was used to evaluate the data. In the study,
descriptive statistics (mean, standard deviation, median,
minimum-maximum values, number and percentile)
were given for categorical and continuous variables.
The homogeneity of the variances was checked with the
Levene test. Normality assumption was checked with the
Shapiro–Wilk test. For the differences between the two
groups, Student’s t-test was used if the parametric test
prerequisites are met; if not, the Mann–Whitney U-test
was used. Relationships between categorical variables were
analyzed with Fisher’s exact test and Pearson’s chi-squared
test. The relationship between two continuous variables
was evaluated with the Pearson correlation coefficient
and Spearman correlation coefficient. Logistic regression
analysis was used when the dependent variable was twolevel. Cut-off scores of patients and healthy individuals
according to measurement parameters were evaluated
by ROC analysis. AUC value, sensitivity, and selectivity
values were

calculated. A p < 0.05 level was considered
statistically significant.
3. Results
3.1. Baseline data
One hundred patients and 50 healthy volunteers were
included in the study. Fifty-seven percent of the patients
were female (n: 57) and 48% (n: 48) were male; 52% of
the control group was female (n: 26) and 48% male (n:
24). The mean age was 66.31 ± 11.947 in the patient group
and 64.9 ± 6.11 in the control group. Sex distribution and
mean age were similar between groups (respectively p =
0.561; p = 0.121).
3.2. Clinical assessment
In the patient group, admission NIHSS, discharge NIHSS,
and discharge mRS scores were evaluated and infarct
volume (ROI (cm3)) was calculated. NIHSS scores were
analyzed in 5 categories; 0–5 were minor, 5–15 were
moderate, 15–20 were severe, 20–42 were very severe and
those of 42 and above were considered exitus. Discharge
mRS scores were examined in 5 groups: 0–1 good, 2–3
moderate, 4–5 were bad, and those of 5 and above were
accepted as exitus. The median (IQR) NIHSS score at
arrival was 6 (1–23), the median (IQR) NIHSS score at
discharge was 6 (0–23), and the mean mRS at discharge
was 3 (0–5), 11 of the patients had a stroke history and 7
had a stroke in their family history. Seventy-five percent
(n: 75) of the patients had hypertension, 52% (n: 52) were
smoking, and 31% (n: 31) had hyperlipidemia. Great artery
atherosclerosis was the most common type of stroke.
3.3. Biochemical assessment
Serum total cholesterol (TC), HDL, low density lipoprotein
(LDL), TG, PON, LOOH, MPO, and MPO/PON values

were evaluated and compared in the patient and control
groups. Except for TG, other measured parameters differed
statistically between the groups. While TC, LDL, LOOH,
MPO levels and MPO/PON ratio were lower in the healthy
control group; HDL and PON were lower in the patient
group. Although the TG level was found to be high in
stroke patients, it did not reach statistical significance (p
> 0.05) (Table 1).
3.4. Biochemical assessment, radiological outcome, and
clinical disability correlations
Correlation analyses were used to determine a relationship
between serum TC, HDL, LDL, TG, PON, LOOH, MPO,
MPO/PON levels and admission/discharge NIHSS,
discharge MRS, and infarct volume (ROI (cm3)). A
weak negative correlation was found between LOOH
and discharge mRS (respectively; r = –0.204; r = –0.244,
p < 0.05). Infarct volume and TG levels were negatively
correlated, MPO/PON ratio was positively correlated
(respectively; r = –0.226, r = 0.204, p < 0.05) (Table 2).
Logistic regression analyses performed to reveal the
factors that may affect stroke severity (NIHSS score 6 and
above) and early disability (mRS score 2 and above) did
not show statistical significance for lipid profile, LOOH,
PON, MPO, MPO/PON. However, for stroke severity,
hypertension (OR = 3.287, 95% CI = 1.080–10.09, p =
0.036), presence of diabetes (OR = 0.292, 95% CI = 0.089–
0.962, p = 0.043), and HbA1c levels (OR = 1.487, 95% CI =
1.096–2.019, p = 0.011); for early disability, diabetes history
(OR = 0.011, 95% CI = 0.000–0.893, p = 0.044), HbA1c
levels (OR = 5.059, 95% CI = 1.222–20.939, p = 0.025),
infarct volume (OR = 1.027, 95% CI = 1.008–1.047, p =
0.005), and NIHSSa score (OR = 21,646, 95% CI = 3.113–
150.524, p = 0.002) were determined as independent risk
factors (Table 3).
ROC curve analyses to show the sensitivity and
specificity of serum parameters in predicting stroke
severity and early disability revealed statistical significance
only for LOOH. When the cut-off point was accepted as
2, LOOH was found with 68.49% sensitivity and 55.56%
specificity (p = 0.0375); when the cut-off point is accepted
as 4, it can predict disability with 76.00% sensitivity and
57.33% specificity in the mRS score for early disability (p =
0.0377) (Table 4) (Figure).
4. Discussion
In this study, we examined the augmentation of lipoprotein
peroxidation, serum oxidative stress parameters, and
dysfunctional evolution of HDL caused by rheological
changes in the cerebrovascular system in the first 24
h of ACI with clinicoradiological and biochemical
correlations. An increase in oxidative stress parameters
and HDL’s dysfunctionality was demonstrated in the
first 24 h which was thought to be an independent risk
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Table 1. Lipid, PON, MPO, LOOH, MPO/PON parameters (mg/dL) in the patient and control groups.
Control group (n = 50)
mean ± SD
[median (min.–max.)]

Patient (n = 100)
mean ± SD
[median (min.–max.)]

p-value

TC

152.32 ± 36.51
[163.00 (63.00–214.00)]

176.33 ± 39.55
[170.00 (94.00–300.00)]

0.007 1**

HDL

43.94 ± 19.04
[43.50 (9.00–95.00)]

37.75 ± 11.86
[35.00 (19.00–106.00)]

0.020 1*

LDL

85,32 ± 29,07
[89.00 (15.00–145.00)]

112.52 ± 36.96
[109.00 (21.00–222.00)]

0.001 1**

TG

120.08 ± 53.29
[106.00 (50.00–327.00)]

156.66 ± 101.99
[118.00 (54.00–555.00)]

0.060

PON

295.51 ± 141.77
[271.26 (74.15–558.28)]

237.78 ± 124.06
[209.33 (26.82–471.49)]

0.014 1*

LOOH

4.67 ± 2.22
[4.01 (2.28–16.92)]

8.03 ± 4.93
[6.14 (2.66–24.53)]

0.001 1**

MPO

43.16 ± 32.69
[34.94 (6.52–184.55)]

96.28 ± 66.94
[76.49 (28.79–312.40)]

0.001 1**

MPO/PON

0.19 ± 0.19
[0.13 (0.04–1.05)]

0.61 ± 0.71
[0.35 (0.09–4.71)]

0.001 1**

**p < 0.01
*p < 0.05 1 Mann–Whitney U test

factor in determining clinical disability in ACI. A positive
correlation was found between dysfunctional HDL and
infarct volume and correlated with poor radiological
outcomes.
Ischemic stroke develops as a result of three basic
mechanisms: thrombotic, embolic, and hemodynamic.
Atherosclerosis is the most important basic process of the
thrombosis and mostly develops because of factors such
as hypertension, diabetes, dyslipidemia, and smoking
[12]. Among the demographic data of 100 patients
diagnosed with acute ischemic stroke, atherosclerotic
stroke was found to be the first (87%) of stroke types and
the most common risk factors were hypertension (46%),
dyslipidemia (46%), and diabetes mellitus (34%).
The atherosclerotic process adversely affects the
rheological balance in both macro and microvascular areas
in dyslipidemic patients, and even this process begins 2 or
more years before the onset of stroke [13,14]. Hoshino
et al. [15] investigated the serum lipid profile in 792
patients with ACI and found that the rate of atherogenic
dyslipidemia was 12.2% in the first week, the rate of
intracranial artery stenosis was higher in these patients,
and major adverse cardiovascular events (24.5%) and
ischemic stroke (16.8%) were more common at the end
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of 1 year. In the present study, dyslipidemia was present
in 46% (n: 46) of the patient group. In addition, TC and
LDL values showed statistically significant differences
compared to the control group. Except for serum TG,
other findings were higher and serum HDL level was
lower in the patient group. There was a weak negative
correlation between serum TG levels and infarct volume
(r = 0.246, p < 0.05). In this respect, a similar study was
conducted by Pikija et al. [16] in 121 ACI patients. The
relationship between infarct volume and fasting serum TG
level taken within the first 24 h after hospitalization was
investigated, and an independent relationship was shown
between fasting serum TG levels and lower infarct volume.
Our findings complement and align with reports based on
clinical outcomes [17,18].
MPO is an acute phase reactant, generating free
radicals and diffuse oxidants with antimicrobial activity,
and promoting oxidative damage to major tissues,
including atherosclerotic lesions at inflammation
sites [19,20]. Besides the proinflammatory effect, new
evidence points to a role for MPO-generated oxidants
as participants in rendering HDL dysfunctional within
human atherosclerotic plaque by binding to HDL within
human atherosclerotic lesions via specific interactions
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Table 2. Correlation between stroke severity, early disability, infarct volume, and lipid profile, PON, LOOH, MPO, MPO/PON.

TC
HDL
LDL
TG
PON
LOOH
MPO
MPO/PON

Arrival NIHSS

Discharge NIHSS

Discharge mRS

ROI (cm3)

R

0.016

0.006

–0.013

–0.196

P

0.872

0.954

0.896

0.051

R

–0.029

–0.052

–0.024

–0.090

P

0.771

0.608

0.816

0.376

R

0.075

0.045

0.059

–0.114

P

0.456

0.655

0.563

0.259

R

–0.051

0.026

–0.049

–0.226*

P

0.614

0.799

0.630

0.024

R

–0.204*

–0.150

–0.093

–0.194

P

0.042

0.137

0.359

0.054

R

–0.195

–0.170

–0.244*

–0.111

P

0.051

0.090

0.015

0.273

R

0.011

–0.041

–0.020

0.108

P

0.912

0.682

0.845

0.285

R

0.100

0.032

0.008

0.204*

P

0.324

0.749

0.933

0.042

*p < 0.05
**p < 0.01
1
Spearman’s correlation coefficient
Table 3. Logistic regression analysis for possible factors predicting stroke severity and early disability.
Stroke Severity (NIHSS > 6)

Disability (mRS > 2)

Odds ratio

%95 CI

p

HT

3.287

1.080–10.009

0.036 *

Odds ratio

%95 CI

p

Diabetes mellitus

0.292

0.089–0.962

HbA1c

1.487

1.096–2.019

0.043 *

0.011

0.000–0.893

0.044 *

0.011 *

5.059

1.222–20.939

0.025 *

ROI (cm )

1.027

1.008–1.047

0.005 **

NIHSS

21.646

3.113–150.524

0.002 **

-2 Log likelihood = 120.620
Cox & Snell R square = 0.159
Nagelkerke R square = 0.213
x2 = 17.369

-2 Log likelihood = 21.008
Cox & Snell R square = 0.616
Nagelkerke R square = 0.894
x2 = 95.644

3

**p < 0.01
*p < 0.05

with apolipoprotein (apo) A-I, the predominant protein
of HDL [21]. In the study of Cojocaru et al. [22], in acute
stroke patients, MPO levels looked at in the first 24 h were
found to be significantly higher and thought to be used
for diagnostic purposes. In our study, MPO activity was
higher in the patient group (96.28 ± 66.94) (p < 0.01)

which shows that oxidative stress in the early acute phase
both sets the stage for ischemia by affecting the rheological
order quantitatively and also affects the antiinflammatory
mechanisms qualitatively since this parameter is an
indirect indicator of dysfunctional HDL formation.
HDL particles, which perform many functions, such
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Table 4. ROC curve analysis of LOOH for mRS ≥ 2 (left) and mRS ≥ 4 (right).

mRS

Break
point

Sensitivity

95% CI

Specificity 95% CI

Area under the ROC
curve (AUC)

95% CI

p

LOOH

mRS ≥ 2

7.22

68.49

56.6–78.9

55.56

35.3–74.5

0.628

0.526–0.723

0.0375

LOOH

mRS ≥ 4

6.2

76.00

54.9–90.6

57.33

45.4–68.7

0.638

0.535–0.731

0.0377

Figure. ROC curve analysis of LOOH for mRS ≥ 2 (left) and mRS ≥ 4 (right).

as the regulation of cholesterol and protein transport,
are considered “functional”, while the otherwise called
“dysfunctional”. Low HDL-C levels are associated with the
development of cardiovascular diseases and pose a risk for
recurrent cerebral ischemic events [23,24]. Characteristic
features of dysfunction include decreased activity in its
function and components, such as PON1 and apoA-1.
In this context, HDL function, PON1 enzyme activity,
and eNOS expression values will guide the diagnosis of
endothelial dysfunction [25]. In a study by Haraguchi et al.,
the correlation between MPO and PON and the formation
of dysfunctional HDL, and in this context, their effects on
coronary risk stratification and function of lipoproteins
were investigated in 158 coronary artery patients. The high
MPO/PON1 ratio was independently correlated with the
ischemic effect on coronary arteries and concluded that
the MPO/PON1 ratio is associated with HDL dysfunction,
which can be used as an independent biomarker [10].
In our study, PON activity was lower (237.78 ± 124.06)
and the ratio of MPO/PON, which affects and alters the
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function of HDL, was shown to be higher in the patient
group (0 ± 61 ± 0.71) (p < 0.01). We concluded that this
increase will constitute one of the major etiological factors
of ACI by creating a series of rheological changes in the
cerebrovascular system, from oxidative modifications of
lipoproteins to vascular inflammation.
Paraoxanase is a hydrolase enzyme that is synthesized
by the liver and released into the serum, where associated
with HDL functionality [26]. Reduced activity of PON1
has been implicated in the development of atherosclerosis
[27]. Moreover, during this process, MPO generates the
oxidants hypochlorous acid and nitrogen dioxide, which
can lead to posttranslational modification of PON1,
including tyrosine modifications that inhibit PON1
activity [28]. In Chawhan et al.’s study [29], PON1 activity
was measured spectrophotometrically in 50 ischemic
stroke patients and 50 healthy controls and was found to
be decreased significantly in patients (p < 0.001). KoturStevuljevic et al. investigated oxidative stress status, PON1
status, lipids, and high-sensitivity C-reactive protein

DEMİR ÜNAL et al. / Turk J Med Sci
(hsCRP) in 185 ACI patients and found decreased HDLcholesterol level and a remarkable fall in PON1 activity
than controls (p < 0.001), along with more prominent
inflammation [30]. In our study, PON1 was found to be
lower in the patient population (p < 0.01, p < 0.05) which
shows the imbalance in prooxidative-antioxidative status.
In one study, serum PON level, NIHSS score and ischemic
volume were compared in terms of stroke risk factors
in 34 ACI patients in the first 72–96 h and a significant
decrease in serum PON values of the patient group was
determined (p < 0.001) [31]. Xu et al. investigated the
relationship between serum PON1 activity and functional
outcome in 336 ACI patients and found a significant
decrease in the mRS score across serum PON1 quartiles
which concluded that serum PON1 activity may be an
independent predictor of the functional outcome in
ACI [32]. Moreover, Ferretti et al. showed a negative
correlation between the PON1 activity and the values of
the NIHSS in 49 ACI patients [33]. Our study showed a
negative relationship between PON1 activity and arrival
NIHSS (r = 0.204 p < 00.05) which confirms that subjects
with lower PON1 activity are more exposed to clinical
disability.
LOOH is the first by-product of oxidized lipids and
serum level determination is important [34]. Ferretti
et al. [33] compared paraoxanase activity and plasma
lipid hydroperoxide levels in 49 stroke patients and
demonstrated that the activity of PON1 was significantly
lower (p: 0.001) and the levels of lipid hydroperoxides were
significantly higher in stroke patients (p: 0.001). Moreover,
a positive correlation between the individual values of
lipid hydroperoxides and the NIHSS score was found,
which confirms a relationship between oxidative damage
and neurological impairment in patients. We measured
the LOOH level as an index of lipid peroxidation and was
found to be higher in the patient group (8.03 ± 4.93) than
in the control group (4.67 ± 2.22) (p < 0.01). The ROC
analysis revealed that the LOOH parameter was a good
predictor of functional outcomes.
Derex et al. showed that arrival NIHSS scores were
correlated with acute DWI lesion volumes (r = 0.71), and
the NIHSS score was associated with arterial occlusion
[35]. In another study, infarct volume and NIHSS scale
were monitored over 7 days in 375 ACI patients with
known diabetes history or HbA1c value ≥6.5%, and
multivariate regression analysis showed that high glucose
level was independently associated with infarct volume
growth in all patients [36]. In addition, high glucose levels
have been proven to be independently associated with
neurological worsening in all patients. Logistic regression
analyses showed diabetes and elevated HbA1c levels to be
an independent predictor of stroke severity (OR = 1.487,
95% CI = 1.096–2.019, p = 0.011). Both HbA1C and

infarct volume were found to be effective in prepredicting
early disability (respectively OR = 5.059, 95% CI = 1.222–
20.939, p = 0.025; OR = 1.027, 95% CI = 1.008–1.047, p =
0.005).
As for the limitations of the study,
the present study was based on a detailed interview
with the patient (and/or a caregiver) that was carried out
within 24 h of hospital admission for acute stroke. The
parameters examined within the study do not include
the significance level of the parameters that have reached
statistical significance in subacute or chronic return of
stroke. In addition, the limited patient population included
in the study brings to mind the idea that different results
can be obtained when similar studies are conducted with
larger patient groups of different ethnic origins.
6. Conclusion
In summary, ACI process is the result of dysregulation of
the oxidative/antioxidative process and MPO plays a role
in the oxidation of LDL also a decrease in HDL-related
functional PON1, which indicates HDL dysfunction. An
increase in MPO enzyme activity leads to an increase in
dysfunctional HDL. Although cardiovascular disease
publications are remaining valid that lipid-lowering drugs
reduces stroke recurrence, there is no proven study yet that
reveals whether stroke severity, ischemia, HDL level of
atherosclerosis or its functional capacity are related. In this
respect, our study will be seminal in terms of both treatment
principles and the detection of pathophysiological and
therapeutic approaches. Moreover, our study is valuable
to show the correlation between dysfunctional HDL,
infarction volume and stroke severity in stroke patients.
The thought that the qualitative value may be more
important than the quantitative measurement of serum
lipid levels seems to deserve consideration. Therefore,
dysfunctional HDL should be included in the lipid profile
test battery when evaluating stroke patients.
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